{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T19:57:38Z","timestamp":1789934258494,"version":"4.0.1"},"reference-count":32,"publisher":"Oxford University Press (OUP)","issue":"18","license":[{"start":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T00:00:00Z","timestamp":1626652800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,2,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Aims<\/jats:title>\n                  <jats:p>This study aimed to investigate additional risk stratification benefits of hepatic steatosis (HS) concurrently assessed during coronary computed tomography angiography (CTA) in a large patient cohort with suspected stable coronary artery disease (CAD).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods and results<\/jats:title>\n                  <jats:p>In this prospective study, 1148 Japanese outpatients without a history of CAD who underwent coronary CTA for suspected stable CAD (mean age 64\u2009\u00b1\u200914\u2009years) were included. HS, defined on CT as a hepatic-to-spleen attenuation ratio of &amp;lt;1.0, was examined just before the evaluation of adverse CTA findings, defined as obstructive and\/or high-risk plaque. The major adverse cardiac events (MACE) were the composite of cardiac death, acute coronary syndrome, and late revascularization. The incremental predictive value of HS was evaluated using the global \u03c72 test and C-statistic. HS was identified in 247 (22%) patients. During a median follow-up of 3.9\u2009years, MACE was observed in 40 (3.5%) patients. HS was significantly associated with MACE in a model that included adverse CTA findings (hazard ratio 4.01, 95% confidence interval 2.12\u20137.59, P\u2009&amp;lt;\u20090.001). By adding HS to the Framingham risk score and adverse CTA findings, the global \u03c72 score and C-statistic significantly increased from 29.0 to 49.5 (P\u2009&amp;lt;\u20090.001) and 0.74 to 0.81 (P\u2009=\u20090.026), respectively. In subgroup analyses in patients with diabetes mellitus and metabolic syndrome, HS had significant additive predictive value for MACE over the Framingham risk score and adverse CTA findings.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>In patients with suspected stable CAD, concurrent evaluation of HS during coronary CTA enables more accurate detection of patients at higher risk of MACE.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/eurjpc\/zwab120","type":"journal-article","created":{"date-parts":[[2021,6,26]],"date-time":"2021-06-26T11:11:16Z","timestamp":1624705876000},"page":"2059-2066","source":"Crossref","is-referenced-by-count":37,"title":["Incremental prognostic value of non-alcoholic fatty liver disease over coronary computed tomography angiography findings in patients with suspected coronary artery disease"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0657-514X","authenticated-orcid":false,"given":"Keishi","family":"Ichikawa","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9039-3439","authenticated-orcid":false,"given":"Toru","family":"Miyoshi","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Osawa","sequence":"additional","affiliation":[{"name":"Department of General Internal Medicine 3, Kawasaki Medical School General Medical Center, Okayama, Japan, Okayama 700-8505, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Miki","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironobu","family":"Toda","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Ejiri","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazufumi","family":"Nakamura","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6419-1246","authenticated-orcid":false,"given":"Hiroshi","family":"Morita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Therapeutics, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ito","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Kita-ku, Okayama 700-8558, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,19]]},"reference":[{"key":"2022020922032879600_zwab120-B1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2015.12.018","article-title":"Management of residual risk after statin therapy","volume":"245","author":"Reith","year":"2016","journal-title":"Atherosclerosis"},{"key":"2022020922032879600_zwab120-B2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jacc.2007.03.044","article-title":"Multislice computed tomographic characteristics of coronary lesions in acute coronary syndromes","volume":"50","author":"Motoyama","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"2022020922032879600_zwab120-B3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2008.08.058","article-title":"Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study","volume":"52","author":"Meijboom","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2022020922032879600_zwab120-B4","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","article-title":"Diagnostic performance of coronary angiography by 64-row CT","volume":"359","author":"Miller","year":"2008","journal-title":"N Engl J Med"},{"key":"2022020922032879600_zwab120-B5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2010.12.006","article-title":"In vivo CT detection of lipid-rich coronary artery atherosclerotic plaques using quantitative histogram analysis: a head to head comparison with IVUS","volume":"215","author":"Marwan","year":"2011","journal-title":"Atherosclerosis"},{"key":"2022020922032879600_zwab120-B6","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.jacc.2015.05.069","article-title":"Plaque characterization by coronary computed tomography angiography and the likelihood of acute coronary events in mid-term follow-up","volume":"66","author":"Motoyama","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2022020922032879600_zwab120-B7","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1161\/CIRCULATIONAHA.116.024360","article-title":"Prognostic value of noninvasive cardiovascular testing in patients with stable chest pain: insights from the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain)","volume":"135","author":"Hoffmann","year":"2017","journal-title":"Circulation"},{"key":"2022020922032879600_zwab120-B8","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1001\/jamacardio.2017.4973","article-title":"Use of high-risk coronary atherosclerotic plaque detection for risk stratification of patients with stable chest pain: a secondary analysis of the PROMISE randomized clinical trial","volume":"3","author":"Ferencik","year":"2018","journal-title":"JAMA Cardiol"},{"key":"2022020922032879600_zwab120-B9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jhep.2016.05.013","article-title":"Non-alcoholic fatty liver disease and risk of incident cardiovascular disease: a meta-analysis","volume":"65","author":"Targher","year":"2016","journal-title":"J Hepatol"},{"key":"2022020922032879600_zwab120-B10","doi-asserted-by":"crossref","first-page":"S209","DOI":"10.1016\/j.dsx.2016.12.033","article-title":"Nonalcoholic fatty liver disease and the risk of clinical cardiovascular events: a systematic review and meta-analysis","volume":"11","author":"Mahfood Haddad","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"2022020922032879600_zwab120-B11","doi-asserted-by":"crossref","first-page":"33386","DOI":"10.1038\/srep33386","article-title":"Association of non-alcoholic fatty liver disease with major adverse cardiovascular events: a systematic review and meta-analysis","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"key":"2022020922032879600_zwab120-B12","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.acra.2012.02.022","article-title":"Computed tomography scans in the evaluation of fatty liver disease in a population based study: the multi-ethnic study of atherosclerosis","volume":"19","author":"Zeb","year":"2012","journal-title":"Acad Radiol"},{"key":"2022020922032879600_zwab120-B13","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jcmg.2020.01.022","article-title":"Prognostic value of coronary computed tomographic angiography in patients with nonalcoholic fatty liver disease","volume":"13","author":"Ichikawa","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2022020922032879600_zwab120-B14","doi-asserted-by":"crossref","first-page":"e0131138","DOI":"10.1371\/journal.pone.0131138","article-title":"Nonalcoholic hepatic steatosis is a strong predictor of high-risk coronary-artery plaques as determined by multidetector CT","volume":"10","author":"Osawa","year":"2015","journal-title":"PLoS One"},{"key":"2022020922032879600_zwab120-B15","doi-asserted-by":"crossref","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","article-title":"Nonalcoholic fatty liver disease","volume":"1","author":"Brunt","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"2022020922032879600_zwab120-B16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2019.01.032","article-title":"Decrease in oxidized high-density lipoprotein is associated with slowed progression of coronary artery calcification: Subanalysis of a prospective multicenter study","volume":"283","author":"Miki","year":"2019","journal-title":"Atherosclerosis"},{"key":"2022020922032879600_zwab120-B17","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1161\/CIRCULATIONAHA.105.169404","article-title":"Diagnosis and management of the metabolic syndrome: an American Heart Association\/National Heart, Lung, and Blood Institute Scientific Statement","volume":"112","author":"Grundy","year":"2005","journal-title":"Circulation"},{"key":"2022020922032879600_zwab120-B18","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"2022020922032879600_zwab120-B19","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1002\/ehf2.13317","article-title":"Fibrosis-4 index reflects right ventricular function and prognosis in heart failure with preserved ejection fraction","volume":"8","author":"Nakashima","year":"2021","journal-title":"ESC Heart Fail"},{"key":"2022020922032879600_zwab120-B20","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.mayocp.2013.12.015","article-title":"Ethnic and sex differences in fatty liver on cardiac computed tomography: the multi-ethnic study of atherosclerosis","volume":"89","author":"Tota-Maharaj","year":"2014","journal-title":"Mayo Clin Proc"},{"key":"2022020922032879600_zwab120-B21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1148\/rg.295085186","article-title":"Imaging-based quantification of hepatic fat: methods and clinical applications","volume":"29","author":"Ma","year":"2009","journal-title":"Radiographics"},{"key":"2022020922032879600_zwab120-B22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1148\/radiology.211.1.r99ap15283","article-title":"Abdominal fat: standardized technique for measurement at CT","volume":"211","author":"Yoshizumi","year":"1999","journal-title":"Radiology"},{"key":"2022020922032879600_zwab120-B23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jcct.2016.04.005","article-title":"An expert consensus document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Cardiology","volume":"10","author":"Cury","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"2022020922032879600_zwab120-B24","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jacc.2018.11.050","article-title":"Nonalcoholic fatty liver disease and the heart: JACC State-of-the-Art Review","volume":"73","author":"Stahl","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"2022020922032879600_zwab120-B25","doi-asserted-by":"crossref","first-page":"1000344","DOI":"10.4172\/2155-9880.1000344","article-title":"Association between inflammatory markers and liver fat: the multi-ethnic study of atherosclerosis","volume":"5","author":"Hamirani","year":"2014","journal-title":"J Clin Exp Cardiol"},{"key":"2022020922032879600_zwab120-B26","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jhep.2016.04.005","article-title":"Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications","volume":"65","author":"Francque","year":"2016","journal-title":"J Hepatol"},{"key":"2022020922032879600_zwab120-B27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279 013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"key":"2022020922032879600_zwab120-B28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00059-020-04935-x","article-title":"ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: Recommendations for cardiovascular imaging","volume":"45","author":"Saraste","year":"2020","journal-title":"Herz"},{"key":"2022020922032879600_zwab120-B29","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4250\/jcu.2012.20.3.126","article-title":"Relationship between nonalcoholic fatty liver disease and carotid artery atherosclerosis beyond metabolic disorders in non-diabetic patients","volume":"20","author":"Kang","year":"2012","journal-title":"J Cardiovasc Ultrasound"},{"key":"2022020922032879600_zwab120-B30","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.dld.2016.09.002","article-title":"Nonalcoholic fatty liver disease is associated with coronary artery calcification: a systematic review and meta-analysis","volume":"48","author":"Jaruvongvanich","year":"2016","journal-title":"Dig Liver Dis"},{"key":"2022020922032879600_zwab120-B31","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/hep.28253","article-title":"Long-term clinical outcomes after fatty liver screening in patients undergoing coronary angiogram: a prospective cohort study","volume":"63","author":"Wong","year":"2016","journal-title":"Hepatology"},{"key":"2022020922032879600_zwab120-B32","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jcct.2018.07.001","article-title":"Coronary plaque characteristics in computed tomography and 2-year outcomes: The PREDICT study","volume":"12","author":"Yamamoto","year":"2018","journal-title":"J Cardiovasc Comput Tomogr"}],"container-title":["European Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/18\/2059\/42465019\/zwab120.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurjpc\/article-pdf\/28\/18\/2059\/42465019\/zwab120.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T22:05:22Z","timestamp":1644444322000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurjpc\/article\/28\/18\/2059\/6323690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,19]]},"references-count":32,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2021,7,19]]},"published-print":{"date-parts":[[2022,2,9]]}},"URL":"https:\/\/doi.org\/10.1093\/eurjpc\/zwab120","relation":{},"ISSN":["2047-4873","2047-4881"],"issn-type":[{"value":"2047-4873","type":"print"},{"value":"2047-4881","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,12,1]]},"published":{"date-parts":[[2021,7,19]]}}}